ZLABZai Lab Limited

ZLAB Stock Price, Valuation & Chart | Zai Lab Limited

Compare

$23.190-0.32 (-1.36%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology

Overview Financials Dividends Ratios

ZLAB Historical price chart

ZLAB Key Stats

Market Capitalization2.60B

PE Ratio-13.56

EPS-1.71

Trading Volume843.21K

Today's High/Low24.19/23.15

Dividend Yield0.00

52 Week High/Low29.77/15.96

Shares Outstanding112.27M

ZLAB Financial Statement

ZLAB Analyst ratings

ZLAB Analysis & performance metrics

ZLAB Company profile

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong…

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure…

ZLAB Management team

Name

Position

Rafael G. Amado M.D.

President and Head of Global Research & Development

Tong Zhu

Chief Commercial Officer of Greater China

Yajing Chen Ph.D.CFO

Chief Financial Officer

Frazor Titus Edmondson III, J.D.

Chief Legal Officer & Joint Corporate Secretary

Robert J. Brown M.D.

Chief Medical Officer of Oncology

Christine Chiou

Senior Vice President & Head of Investor Relations

Jonathan J. Wang MBA, Ph.D.

Chief Business Officer

James Yan DABT, M.D., Ph.D.COO

Chief Operating Officer of R&D

Name

Position

Rafael G. Amado M.D.

President and Head of Global Research & Development

Tong Zhu

Chief Commercial Officer of Greater China

Yajing Chen Ph.D.CFO

Chief Financial Officer

Frazor Titus Edmondson III, J.D.

Chief Legal Officer & Joint Corporate Secretary

Robert J. Brown M.D.

Chief Medical Officer of Oncology

Christine Chiou

Senior Vice President & Head of Investor Relations

Jonathan J. Wang MBA, Ph.D.

Chief Business Officer

James Yan DABT, M.D., Ph.D.COO

Chief Operating Officer of R&D

Management Team

Rafael G. Amado M.D.

President and Head of Global Research & Development

Tong Zhu

Chief Commercial Officer of Greater China

Yajing Chen Ph.D.CFO

Chief Financial Officer

Frazor Titus Edmondson III, J.D.

Chief Legal Officer & Joint Corporate Secretary

Robert J. Brown M.D.

Chief Medical Officer of Oncology

Christine Chiou

Senior Vice President & Head of Investor Relations

Jonathan J. Wang MBA, Ph.D.

Chief Business Officer

James Yan DABT, M.D., Ph.D.COO

Chief Operating Officer of R&D

Management

Rafael G. Amado M.D.

President and Head of Global Research & Development

Tong Zhu

Chief Commercial Officer of Greater China

Yajing Chen Ph.D.CFO

Chief Financial Officer

Frazor Titus Edmondson III, J.D.

Chief Legal Officer & Joint Corporate Secretary

Robert J. Brown M.D.

Chief Medical Officer of Oncology

Christine Chiou

Senior Vice President & Head of Investor Relations

Jonathan J. Wang MBA, Ph.D.

Chief Business Officer

James Yan DABT, M.D., Ph.D.COO

Chief Operating Officer of R&D

Total 8 executives

ZLAB Frequently asked questions

What is Zai Lab Limited (ZLAB) Stock Price?

Current stock price of Zai Lab Limited (ZLAB) stock is $23.190. The stock price is -1.36% lower in the session. The intraday range can be seen from this page. Volume of Zai Lab Limited (ZLAB) stock is 843.21K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Zai Lab Limited (ZLAB) stock price going up or down today?

The stock price of Zai Lab Limited (ZLAB) can change with earnings, company news, and overall market sentiment. Zai Lab Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Zai Lab Limited stock expensive at its current price?

Whether Zai Lab Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ZLAB on this page is -13.56. EPS on this page is -1.71. Compare those figures with peers and growth expectations before deciding if the current Zai Lab Limited price is justified.

How has the stock price of Zai Lab Limited (ZLAB) performed historically?

Historical performance for Zai Lab Limited (ZLAB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ZLAB reacted to past earnings and market events.

Should I buy Zai Lab Limited (ZLAB) stock, at this price?

Buying Zai Lab Limited (ZLAB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.